Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Input Will Bolster Risk-Based Inspection Approach – FDA’s Ellsworth

This article was originally published in The Tan Sheet

Executive Summary

FDA is "hoping" to use future facility inspections to compile data that will strengthen the "process risk" prong of its risk-based site selection model by gaining knowledge about quality systems currently in use by industry, according to New Jersey District Director Douglas Ellsworth
Advertisement

Related Content

Experts Address Chondroitin Testing In Wake Of ConsumerLab Report
Experts Address Chondroitin Testing In Wake Of ConsumerLab Report
Experts Address Chondroitin Testing In Wake Of ConsumerLab Report
FDA public meeting
FDA public meeting
FDA public meeting
Fewer Warning Letters: Does Change Point To FDA Advancement Or Decline?
Fewer Warning Letters: Does Change Point To FDA Advancement Or Decline?
OTC Manufacturers Less Likely To Face Inspection Under cGMP Pilot
OTC Manufacturers Less Likely To Face Inspection Under cGMP Pilot

Topics

Advertisement
UsernamePublicRestriction

Register

PS099516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel